Two boys walking on grasses during daytime.There’s new data supporting the use of Epidiolex — the first cannabidiol (CBD) medicine approved by the U.S. Food and Drug Administration — to help curb a form of epilepsy.

The research found that the drug reduced seizures by nearly half in children with Dravet syndrome, a rare and severe form of the neurological disorder.

The FDA approved Epidiolex last fall for the treatment of Dravet syndrome and another rare but severe form of childhood epilepsy, Lennox-Gastaut syndrome. The new study was funded by GW Research Ltd., developer of Epidiolex.

Read more: https://www.webmd.com/epilepsy/news/20190430/more-evidence-backs-cbd-for-kids-rare-epilepsy#

1
Feel free to ask us any questions!
Powered by